Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Hematology

Staying Healthy: Standard of Care for S-HPFH

At a Glance

S-HPFH is a mild variant of sickle cell disease where naturally high levels of fetal hemoglobin protect the body. Most patients live normal lives and do not require intensive sickle cell treatments like daily penicillin or hydroxyurea, needing only occasional hematology check-ins.

Once an S-HPFH diagnosis is confirmed by genetic testing, the focus of medical care shifts from managing a chronic illness to maintaining wellness. Because S-HPFH is a significantly milder condition than classic sickle cell anemia (HbSS), many of the intensive treatments that are standard for other sickle cell patients are often unnecessary [1][2].

Tailoring Your Care Plan

In many cases of sickle cell disease, aggressive preventative measures are required to protect the body from damage. However, for those with confirmed S-HPFH, research supports tailoring care to avoid unnecessary interventions [1]:

  • Stopping Routine Penicillin: While all infants with an “FS” newborn screen must take penicillin initially, doctors usually stop this medication once genetic testing definitively confirms S-HPFH. Because people with S-HPFH typically keep a healthy, functioning spleen, this daily medication is no longer required [1][3].
  • No Routine TCD Scans: Transcranial Doppler (TCD) scans are specialized ultrasounds used to check stroke risk in children with HbSS. Since the risk of stroke in S-HPFH is extremely low, these annual scans are generally not recommended [1][2].
  • No Hydroxyurea: Hydroxyurea is a medication used to boost fetal hemoglobin (HbF) levels in sickle cell patients. Since people with S-HPFH naturally have very high, protective levels of HbF, there is typically no need for this medication [2][4].

Recommended Monitoring

While “intensive” care isn’t usually needed, “intentional” care still matters. A hematologist (blood specialist) will likely recommend a lighter schedule of monitoring:

  • Periodic Check-ins: You may only need to see a hematologist once a year or every few years if you are entirely asymptomatic [1][5].
  • Establishing a Baseline: It is helpful to have occasional CBC (Complete Blood Count) and reticulocyte count (a measure of how fast your body makes red blood cells) tests. This helps your doctor know what “normal” looks like for you [6].
  • Spleen Evaluation: Your doctor may occasionally check your abdomen to ensure your spleen remains healthy and active [3].

Family Planning and Genetics

It is crucial to remember that having S-HPFH means you carry the Sickle Cell trait (HbS). If you plan to have children, your partner should be tested for the sickle cell trait (HbAS) before conceiving [7]. If your partner also carries the sickle cell trait, there is a risk of having a child with severe Sickle Cell Anemia (HbSS), because you could pass on your ‘S’ gene and your partner could pass on theirs [7][8]. Meeting with a genetic counselor can help you navigate these family planning decisions with clarity.

Living a Full Life: Precautions and Scenarios

Living with S-HPFH usually means having a normal life expectancy and a quality of life similar to the general population [5][1]. However, it is wise to be mindful of a few specific situations:

  • Extreme Altitudes: Very high altitudes (like mountain climbing or unpressurized aircraft) have lower oxygen levels. It is a good idea to stay well-hydrated and move slowly in these environments to avoid putting stress on your red blood cells [5].
  • Pregnancy: While S-HPFH is a mild condition, pregnancy adds stress to the body. You do not necessarily need a high-risk pregnancy specialist, but your regular obstetrician should consult with your hematologist to ensure your blood counts and overall health are monitored appropriately [5].

Ultimately, the most important “treatment” for S-HPFH is accurate education. Ensuring that every doctor you see understands that your condition is a mild variant rather than a severe disease prevents unnecessary medical interventions and allows you to live with confidence [8][2].

Common questions in this guide

Do I need to take hydroxyurea or daily penicillin for S-HPFH?
Generally, no. Because S-HPFH is much milder than classic sickle cell anemia, intensive medications like daily penicillin or hydroxyurea are typically unnecessary. Your doctor will likely stop these once genetic testing confirms your diagnosis.
Will my child need regular transcranial Doppler (TCD) scans with S-HPFH?
Routine TCD scans are generally not recommended for S-HPFH. These specialized ultrasounds monitor stroke risk in children with severe sickle cell disease, but the risk of stroke in S-HPFH is extremely low.
How often do I need to see a hematologist for S-HPFH?
You may only need to see a hematologist once a year or every few years, especially if you have no symptoms. These visits usually involve basic blood tests and a quick check of your spleen to establish a healthy baseline.
Can I pass sickle cell disease to my children if I have S-HPFH?
Yes. Because having S-HPFH means you carry the sickle cell trait (HbS), you can pass this gene to your children. If your partner also carries a sickle cell trait, your child could be born with severe sickle cell anemia, making genetic counseling very important.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my confirmed S-HPFH diagnosis, can we officially stop the standard sickle cell treatments like daily penicillin or routine TCD scans?
  2. 2.Can we schedule a genetic counseling session or order carrier testing for my partner to understand the risks for our future children?
  3. 3.How often should I have my blood counts (CBC and reticulocyte count) checked to establish a healthy baseline for me?
  4. 4.Do I still need to see a hematologist regularly, or can my care be managed primarily by my primary doctor?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Sickle cell disease severity: an introduction.

    Pace BS, Goodman SR

    Experimental biology and medicine (Maywood, N.J.) 2016; (241(7)):677-8 doi:10.1177/1535370216641880.

    PMID: 27190296
  2. 2

    The Natural History of Hb S/Hereditary Persistence of Fetal Hemoglobin in 13 Children from the State of Minas Gerais, Brazil.

    Belisário AR, Sales RR, Silva CM, et al.

    Hemoglobin 2016; (40(3)):215-9 doi:10.3109/03630269.2016.1149076.

    PMID: 27117574
  3. 3

    Fetal hemoglobin and hemolysis markers in sickle cell anemia.

    Colella MP, Traina F

    Revista brasileira de hematologia e hemoterapia 2015; (37(3)):148-9.

    PMID: 26041414
  4. 4

    Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.

    Quinn CT, Niss O, Dong M, et al.

    British journal of haematology 2021; (194(3)):617-625 doi:10.1111/bjh.17663.

    PMID: 34227124
  5. 5

    A Rare Case of Multiple Bone Infarctions and Abnormal Pulmonary Function Tests in a Patient With Compound Heterozygous Hemoglobin S and Type 2 Hereditary Persistence of Fetal Hemoglobin.

    Alnaqbi KA

    Cureus 2024; (16(8)):e66395 doi:10.7759/cureus.66395.

    PMID: 39113817
  6. 6

    Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience.

    Pandey H, Singh K, Ranjan R, et al.

    Hematology (Amsterdam, Netherlands) 2019; (24(1)):349-352 doi:10.1080/16078454.2019.1579985.

    PMID: 30777489
  7. 7

    Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia.

    Shook LM, Haygood D, Quinn CT

    Frontiers in medicine 2021; (8()):734305 doi:10.3389/fmed.2021.734305.

    PMID: 34859003
  8. 8

    Blessing in disguise; a case of Hereditary Persistence of Fetal Hemoglobin.

    Shaukat I, Pudal A, Yassin S, et al.

    Journal of community hospital internal medicine perspectives 2018; (8(6)):380-381 doi:10.1080/20009666.2018.1536241.

    PMID: 30559951

This page provides educational information about the standard of care for S-HPFH. Always consult your hematologist before making any changes to your medical monitoring or treatment plan.

Get notified when new evidence is published on Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.